114 related articles for article (PubMed ID: 7517877)
1. Expression and function of CD59 on colonic adenocarcinoma cells.
Bjørge L; Vedeler CA; Ulvestad E; Matre R
Eur J Immunol; 1994 Jul; 24(7):1597-603. PubMed ID: 7517877
[TBL] [Abstract][Full Text] [Related]
2. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells.
Hakulinen J; Meri S
Lab Invest; 1994 Dec; 71(6):820-7. PubMed ID: 7528832
[TBL] [Abstract][Full Text] [Related]
3. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
[TBL] [Abstract][Full Text] [Related]
4. CD59 expressed by human endothelial cells functions as a protective molecule against complement-mediated lysis.
Brooimans RA; Van der Ark AA; Tomita M; Van Es LA; Daha MR
Eur J Immunol; 1992 Mar; 22(3):791-7. PubMed ID: 1372260
[TBL] [Abstract][Full Text] [Related]
5. The influence of tumour necrosis factor-alpha, interleukin-1 beta and interferon-gamma on the expression and function of the complement regulatory protein CD59 on the human colonic adenocarcinoma cell line HT29.
Bjørge L; Jensen TS; Ulvestad E; Vedeler CA; Matre R
Scand J Immunol; 1995 Apr; 41(4):350-6. PubMed ID: 7534941
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
[TBL] [Abstract][Full Text] [Related]
7. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
Brooimans RA; van Wieringen PA; van Es LA; Daha MR
Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
[TBL] [Abstract][Full Text] [Related]
8. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.
Mäenpää A; Junnikkala S; Hakulinen J; Timonen T; Meri S
Am J Pathol; 1996 Apr; 148(4):1139-52. PubMed ID: 8644856
[TBL] [Abstract][Full Text] [Related]
9. Expression of protectin (CD59) in human melanoma and its functional role in cell- and complement-mediated cytotoxicity.
Brasoveanu LI; Altomonte M; Gloghini A; Fonsatti E; Coral S; Gasparollo A; Montagner R; Cattarossi I; Simonelli C; Cattelan A
Int J Cancer; 1995 May; 61(4):548-56. PubMed ID: 7538980
[TBL] [Abstract][Full Text] [Related]
10. Effects of complement activation on the expression of CD59 by human mesangial cells.
Shibata T; Kohsaka T
J Immunol; 1995 Jul; 155(1):403-9. PubMed ID: 7541422
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody that blocks the complement regulatory activity of guinea pig erythrocytes and characterization of the antigen involved as guinea pig decay-accelerating factor.
Okada N; Tanaka H; Takizawa H; Okada H
J Immunol; 1995 Jun; 154(11):6103-11. PubMed ID: 7538542
[TBL] [Abstract][Full Text] [Related]
12. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
[TBL] [Abstract][Full Text] [Related]
13. Targeted neutralization of the complement membrane attack complex inhibitor CD59 on the surface of human melanoma cells.
Junnikkala S; Hakulinen J; Meri S
Eur J Immunol; 1994 Mar; 24(3):611-5. PubMed ID: 7510237
[TBL] [Abstract][Full Text] [Related]
14. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59.
Kennedy SP; Rollins SA; Burton WV; Sims PJ; Bothwell AL; Squinto SP; Zavoico GB
Transplantation; 1994 May; 57(10):1494-501. PubMed ID: 7515200
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the membrane attack complex inhibitory protein CD59 antigen on human amniotic cells and in amniotic fluid.
Rooney IA; Morgan BP
Immunology; 1992 Aug; 76(4):541-7. PubMed ID: 1383132
[TBL] [Abstract][Full Text] [Related]
16. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
[TBL] [Abstract][Full Text] [Related]
17. Regulation of CD59 expression on K562 cells: effects of phorbol myristate acetate, cross-linking antibody and non-lethal complement attack.
Marchbank KJ; Morgan BP; van den Berg CW
Immunology; 1995 May; 85(1):146-52. PubMed ID: 7543447
[TBL] [Abstract][Full Text] [Related]
18. Expression of the complement regulatory protein CD59 on human spermatozoa: characterization and role in gametic interaction.
Fenichel P; Cervoni F; Hofmann P; Deckert M; Emiliozzi C; Hsi BL; Rossi B
Mol Reprod Dev; 1994 Jul; 38(3):338-46. PubMed ID: 7522480
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a glycosyl-phosphatidylinositol anchor-deficient subline of Raji cells. An analysis of the functional importance of complement inhibitors on the Raji cell line.
Harris CL; Morgan BP
Immunology; 1995 Oct; 86(2):311-8. PubMed ID: 7490134
[TBL] [Abstract][Full Text] [Related]
20. Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells.
Iborra A; Mayorga M; Llobet N; Martínez P
Cell Immunol; 2003 May; 223(1):46-51. PubMed ID: 12914757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
